[EGFR testing: state of organizations in France in 2010].

doi:10.1016/S0761-8417(11)70002-5

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

[EGFR testing: state of organizations in France in 2010].

Revue de pneumologie clinique - 1 Jun 2011

Nowak F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neoplasms
Share to Genes, erbB-1
Share to Antineoplastic Agents
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomedical Research

Share to Carcinoma, Non-Small-Cell Lung

Share to ErbB Receptors

Share to France

Source

Open in PubMed

Identifiers

PMID: 21777764
DOI: 10.1016/S0761-8417(11)70002-5

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[EGFR testing: state of organizations in France in 2010].PMID 21777764Read ↗

EGFR testing in lung cancer is ready for prime time.Semantic proximity Read ↗

[Presymptomatic testing and predictive testing].Semantic proximity Read ↗

Diagnostics: a testing journey.Semantic proximity Read ↗

[No to patents for genetic diagnostics].Semantic proximity Read ↗

Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing.Semantic proximity Read ↗

A primer on regulation of laboratory-developed testing procedures: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

Reasons to be testing: the dawn of complex molecular profiling in routine oncology practiceSemantic proximity Read ↗

[Genetic analysis after allograft: prudence!].Semantic proximity Read ↗

Lung cancer biomarker testing: perspective from EuropeSemantic proximity Read ↗

Genetic testing provides challenge to insurers.Semantic proximity Read ↗

[Laboratory's function in clinic practice of breast cancer].Semantic proximity Read ↗

[Searching for EGFR: current practices].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.